Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 14;83(19):1886-1901.
doi: 10.1016/j.jacc.2024.01.041.

Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5

Affiliations
Free article
Review

Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5

Roberto J Cubeddu et al. J Am Coll Cardiol. .
Free article

Abstract

Ventricular septal rupture remains a dreadful complication of acute myocardial infarction. Although less commonly observed than during the prethrombolytic era, the condition remains complex and is often associated with refractory cardiogenic shock and death. Corrective surgery, although superior to medical treatment, has been associated with high perioperative morbidity and mortality. Transcatheter closure techniques are less invasive to surgery and offer a valuable alternative, particularly in patients with cardiogenic shock. In these patients, percutaneous mechanical circulatory support represents a novel opportunity for immediate stabilization and preserved end-organ function. Multimodality imaging can identify favorable septal anatomy for the most appropriate type of repair. The heart team approach will define optimal timing for surgery vs percutaneous repair. Emerging concepts are proposed for a deferred treatment approach, including orthotropic heart transplantation in ideal candidates. Finally, for futile situations, palliative care experts and a medical ethics team will provide the best options for end-of-life clinical decision making.

Keywords: cardiogenic shock; heart transplantation; myocardial infarction; percutaneous closure; ventricular septal rupture.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Lorusso has been the principal investigator of PERSIST-AVR (Perceval Sutureless Implant vs Standard Aortic Valve Replacement), sponsored by LivaNova; and has performed consulting for Medtronic, LivaNova, Abiomed, and Eurosets with all honoraria paid to the university. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

MeSH terms

LinkOut - more resources